Jefferies Financial Group Inc. decreased its stake in CVS Health Corporation (NYSE:CVS – Free Report) by 80.9% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 7,814 shares of the pharmacy operator’s stock after selling 33,203 shares during the period. Jefferies Financial Group Inc.’s holdings in CVS Health were worth $670,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently modified their holdings of the company. BlackRock Inc. acquired a new stake in shares of CVS Health in the second quarter valued at approximately $12,747,462,000. State Street Corp increased its position in shares of CVS Health by 26.3% during the 2nd quarter. State Street Corp now owns 74,927,064 shares of the pharmacy operator’s stock valued at $7,751,205,000 after purchasing an additional 15,604,883 shares during the period. Wellington Management Group LLP grew its stake in shares of CVS Health by 49.8% in the 2nd quarter. Wellington Management Group LLP now owns 33,801,113 shares of the pharmacy operator’s stock worth $3,496,725,000 after purchasing an additional 11,233,381 shares during the last quarter. Bank of America Corp DE grew its position in CVS Health by 148.0% in the second quarter. Bank of America Corp DE now owns 23,188,670 shares of the pharmacy operator’s stock worth $2,398,868,000 after buying an additional 13,836,701 shares during the last quarter. Finally, Pzena Investment Management LLC acquired a new position in shares of CVS Health in the 2nd quarter worth $1,217,558,000. Institutional investors and hedge funds own 80.66% of the company’s stock.
Insider Activity at CVS Health
In other CVS Health news, EVP Prem Shah bought 23,855 shares of CVS Health stock in a transaction dated Friday, November 6th. The shares were acquired at an average cost of $83.89 per share, with a total value of $2,001,195.95. Following the acquisition, the executive vice president directly owned 88,516 shares of the company’s stock, valued at $7,425,607.24. The trade was a 36.89% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.85% of the company’s stock.
Analyst Ratings Changes
A number of analysts have commented on the stock. Raymond James Financial set a $103.00 price objective on shares of CVS Health in a research note on Friday, November 6th. JPMorgan Chase & Co. boosted their target price on shares of CVS Health from $111.00 to $118.00 and gave the company an “overweight” rating in a research note on Wednesday, August 12th. UBS Group reduced their target price on CVS Health from $118.00 to $107.00 and set a “buy” rating for the company in a report on Thursday, November 5th. Barclays decreased their target price on CVS Health from $108.00 to $107.00 and set an “overweight” rating for the company in a research report on Thursday, November 5th. Finally, Argus lifted their price target on CVS Health from $104.00 to $114.00 and gave the company a “buy” rating in a report on Wednesday, August 19th. Twenty-three investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, CVS Health presently has a consensus rating of “Moderate Buy” and an average price target of $107.54.
Get Our Latest Stock Report on CVS Health
CVS Health Stock Performance
Shares of CVS opened at $89.37 on Monday. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.66. The company’s fifty day moving average price is $89.65 and its 200 day moving average price is $89.09. The company has a market capitalization of $114.34 billion, a PE ratio of 10.40, a price-to-earnings-growth ratio of 0.78 and a beta of 0.58. CVS Health Corporation has a one year low of $69.51 and a one year high of $110.68.
CVS Health (NYSE:CVS – Get Free Report) last announced its earnings results on Wednesday, November 4th. The pharmacy operator reported $2.09 earnings per share for the quarter, beating the consensus estimate of $1.65 by $0.44. CVS Health had a return on equity of 13.65% and a net margin of 2.62%. The firm had revenue of $108.40 billion during the quarter, compared to the consensus estimate of $104.72 billion. During the same quarter in the prior year, the company earned $1.60 EPS. The firm’s revenue for the quarter was up 5.4% compared to the same quarter last year. As a group, analysts expect that CVS Health Corporation will post 8.26 earnings per share for the current year.
CVS Health Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Monday, November 2nd. Stockholders of record on Thursday, October 22nd were paid a $0.6650 dividend. This represents a $2.66 annualized dividend and a dividend yield of 3.0%. The ex-dividend date was Thursday, October 22nd. CVS Health’s payout ratio is currently 30.97%.
Key CVS Health News
Investors following CVS have been watching these news items:
- Positive Sentiment: A separation could give the pharmacy business and CVS’s other operations sharper strategic focus and improve capital allocation. Some analysts see potential for the pieces to be worth more separately, though the plan is not expected until 2028. CVS Breakup Won’t Satisfy Washington. It Could Still Work for Wall Street.
- Neutral Sentiment: Wells Fargo lowered its price target to $112 from $123 but kept an Overweight rating, signaling a reduced valuation outlook while still seeing potential upside. Wells Fargo analyst rating
- Negative Sentiment: Carving out the retail pharmacies could involve significant execution costs and operational risks, leaving uncertainty about whether the restructuring will deliver the anticipated value. Can CVS Health’s 2028 Split Unlock Value Despite Execution Risks?
CVS Health Company Profile
CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division. The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.
Read More
- Five stocks we like better than CVS Health
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS – Free Report).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.
